期刊文献+

沙格列汀治疗老年糖尿病的效果观察

Effects of Saxagliptin in Elderly Diabetes
原文传递
导出
摘要 目的 探析老年糖尿病患者应用沙格列汀治疗的临床效果.方法 选取我院2015年6月-2016年6月收治的98例老年糖尿病患者,随机分为对照组(n=49)和观察组(n=49).对照组给予二甲双胍治疗,观察组给予沙格列汀治疗,观察两组的临床疗效、心肌酶水平及肝肾功能状况.结果 观察组与对照组的总有效率差异无统计学意义(P〉0.05),但观察组的显效率明显高于对照组(P〈0.05).观察组心肌酶水平明显高于对照组(P〈0.05),肝肾功能明显优于对照组(P〈0.05).结论 应用沙格列汀治疗老年糖尿病临床效果确切,可有效改善患者心肌酶水平及肝肾功能. Objective To explore clinical effects of saxagliptin in elderly diabetes. Methods 98 elderly patients with diabetes mellitus from Jun. 2015 to Jun. 2016 were randomly divided into control group( n=49 )and observation group( n = 49 ). Metformin was used in control group and saxagliptin was used in observation group. Clinical efficacy, levels of myocardial enzymes, liver and kidney function were observed. Results There was no significant difference in total effective rate between the two groups(P 〉0.05 ). The obvious effective rate was significantly higher in observa- tion group than that in control group( P 〈 0.05 ). Levels of myocardial enzymes were higher in observation group than those in control group( P 〈 0. 05 ). Liver and kidney function was significantly better in observation group than that in control group(P 〈 0.05). Conclusion There are definite effects of saxagliptin for the treatment of elderly diabetes, which can improve myocardial enzyme levels as well as liver and kidney function effectively.
作者 曹强
出处 《医学新知》 CAS 2017年第1期62-63,共2页 New Medicine
关键词 老年糖尿病 沙格列汀 临床疗效 心肌酶 肝肾功能 Elderly diabetes Saxagliptin Clinical efficacy Myocardial enzyme Liver and kidney function
  • 相关文献

参考文献8

二级参考文献57

  • 1张幼怡.二甲双胍的心脏保护作用机制研究进展[J].中国医学前沿杂志(电子版),2011,3(5):21-23. 被引量:8
  • 2Matthias Blüher,Ira Kurz,Simone Dannenmaier,Markus Dworak.Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study[J].World Journal of Diabetes,2012,3(9):161-169. 被引量:9
  • 3Inubushi T, Kamemura N, Oda M. L-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats [J]. J Nutr Sci Vitaminol(Tokyo) ,2012 ;58(6) :415-22.
  • 4Hermans MP, Delibasi T, Farmer I. Effects of saxagliptin added to sub- maximal doses of metformin compared with uptitration of metfomain in type 2 diabetes:the PROMPT study[J]. Curt Med Res Opin,2012;28 (10) : 1635-45.
  • 5Barnett AH, Charbonnel B, Donovan M. Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin [ J]. Curt Med Res Opin, 2012 ; 28 (4) :513-23.
  • 6Scheen AJ. Metformin + saxagliptin for type 2 diabetes[J]. Expert Opin Pharmacother,2012 ; 13 ( 1 ) : 139-46.
  • 7Henry R.R, Smith SR, Schwartz S. Effects of saxagliptin on [3-cell stimu- lation and insulin seeretion in patients with type 2 diabetes[J]. Diabetes Obes Metab ,2011,13 (9) :850-8.
  • 8Inubushi T,Kamemura N,Oda M. L-tryptophan suppresses rise in bloodglucose and preserves insulin secretion in type-2 diabetes mellitus rats〔J〕. J Nutr Sci Vitaminol (Tokyo) ,2012;58(6) :415-22.
  • 9Nowicki M, Rychlik I,Haller H. Long-term treatment with the dipeptidylpeptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitusand renal impairment : a randomised controlled 52-week efficacy and safe-ty study〔J〕. Int J Clin Pract,2011 ;65( 12) :1230-9.
  • 10Boulton DW,Li L, Frevert EU. Influence of renal or hepatic impairmenton the pharmacokinetics of saxagliptin(J]. Clin Pharmacokinet,2011 ;50(4) :253-65.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部